• Journals
  • Discipline
  • Indexed
  • Institutions
  • About
JavaScript is disabled for your browser. Some features of this site may not work without it.
View Item 
  •   Home
  • Sociedad Médica de Santiago
  • Revista Médica de Chile
  • View Item
  •   Home
  • Sociedad Médica de Santiago
  • Revista Médica de Chile
  • View Item

INTENSITY ADJUSTMENT OF HEMATOPOIETIC ALOGENEIC TRANSPLANTATION IN ACUTE LEUKEMIA

Ajuste de intensidad para el trasplante hematopoyético alogénico en leucemia aguda.

Author
Sarmiento M, Mauricio

Bertin C, Pablo

Jara, Verónica

Ocqueteau T, Mauricio

Ramírez V, Pablo

Full text
http://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/4971
Abstract
Background: The intensity of conditioning chemotherapy and radiotherapy in hematopoietic stem cell transplantation (HSCT) varies according to several factors including the patient's age, pre-existing conditions and performance status. Myeloablative conditioning (MA) increases transplant related mortality and reduces survival in older patients. Reduced intensity conditioning (RIC) is a good option for these patients. Aim: To report our experience with HSCT in patients of different ages with acute leukemia. Material and methods: Retrospective analysis of 115 allogeneic HSCT performed in patients with acute myeloid or lymphoblastic leukemia. Results: We analyzed the cohort of patients in groups according to age at transplantation: younger than 40 years (n = 74), 41 to 50 years (n = 25) and older than 51 years (n= 16). OS, DFS and relapse at five years were similar in both groups of patients younger than 50 years (OS 40 and 44% respectively, DFS 38 and 42% respectively and relapse 40% and 34% respectively, p = NS). Patients over 51 years had a five years OS of 12%. However when we analyzed those patients by date and conditioning we found that patients who were treated with MA regimens in the first decade of the transplant program (before 2000) had lower OS compared to those treated after 2000 with RIC (five years OS 49% and 12% respectively, p < 0.01). No significant differences in terms of OS, recurrence or incidence of graft-versus-host disease were found when comparing groups under 40 years, between 41 and 50 years and older than 51 years treated only with RIC. Conclusions: RIC provides the possibility of HSCT in older patients with rates comparable to those obtained in younger patients successfully treated with MA conditioning.
 
Background: The intensity of conditioning chemotherapy and radiotherapy in hematopoietic stem cell transplantation (HSCT) varies according to several factors including the patient's age, pre-existing conditions and performance status. Myeloablative conditioning (MA) increases transplant related mortality and reduces survival in older patients. Reduced intensity conditioning (RIC) is a good option for these patients. Aim: To report our experience with HSCT in patients of different ages with acute leukemia. Material and methods: Retrospective analysis of 115 allogeneic HSCT performed in patients with acute myeloid or lymphoblastic leukemia. Results: We analyzed the cohort of patients in groups according to age at transplantation: younger than 40 years (n = 74), 41 to 50 years (n = 25) and older than 51 years (n= 16). OS, DFS and relapse at five years were similar in both groups of patients younger than 50 years (OS 40 and 44% respectively, DFS 38 and 42% respectively and relapse 40% and 34% respectively, p = NS). Patients over 51 years had a five years OS of 12%. However when we analyzed those patients by date and conditioning we found that patients who were treated with MA regimens in the first decade of the transplant program (before 2000) had lower OS compared to those treated after 2000 with RIC (five years OS 49% and 12% respectively, p < 0.01). No significant differences in terms of OS, recurrence or incidence of graft-versus-host disease were found when comparing groups under 40 years, between 41 and 50 years and older than 51 years treated only with RIC. Conclusions: RIC provides the possibility of HSCT in older patients with rates comparable to those obtained in younger patients successfully treated with MA conditioning.
 
Metadata
Show full item record

Related items

Showing items related by title, author, creator and subject.

  • Hypersensitivity reactions associated with the use of asparaginase in children with acute lymphoblastic leukemia 

    Ovalle B., Pilar; Azócar M., Manuel; Nicklas D., Carolina; Villarroel C., Milena; Morales V., Jorge. Revista Chilena de Pediatría; Vol. 92, Núm. 2 (2021): Marzo - Abril; 182-192
  • Leucemia mieloide aguda del adulto: Resultados del Protocolo Nacional de Drogas Antineoplásica. Hospital del Salvador 1990-1998 

    Puga L,Barbara; Cabrera C,María Elena; Undurraga S,María Soledad; Etcheverry B,Raúl; Vacarezza Y,Ricardo; Ducach G,Germán; Toledo G,Humberto. Revista médica de Chile v.128 n.11 2000
  • MYASTENIA GRAVIS AND ITS ASSOCIATION WITH LYMPHOPROLIFERATIVE DISORDERS: A CASE SERRIES 

    Cea, Gabriel; Hospital del Salvador Universidad de Chile; Gallardo V, Andrés; Departamento de Neurociencias Facultad de Medicina Universidad de Chile; Cabrera C, María Elena; Departamento de Hematologia Facultad de Medicina Universidad de Chile. Revista Médica de Chile; Vol. 145, núm. 12 (2017): DICIEMBRE 2017
Discipline
Artes, Arquitectura y UrbanismoCiencias Agrarias, Forestales y VeterinariasCiencias Exactas y NaturalesCiencias SocialesDerechoEconomía y AdministraciónFilosofía y HumanidadesIngenieríaMedicinaMultidisciplinarias
Institutions
Universidad de ChileUniversidad Católica de ChileUniversidad de Santiago de ChileUniversidad de ConcepciónUniversidad Austral de ChileUniversidad Católica de ValparaísoUniversidad del Bio BioUniversidad de ValparaísoUniversidad Católica del Nortemore

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister
Dirección de Servicios de Información y Bibliotecas (SISIB) - Universidad de Chile
© 2019 Dspace - Modificado por SISIB